Recent Analyst Forecasts and Stock Ratings
Faeth Therapeuti FAQ's
Faeth Therapeuti has been rated by research analysts at Guggenheim, UBS, Needham, Raymond James, Oppenheimer, Robert W. Baird in the past 90 days.
Faeth Therapeuti has been rated by research analysts at Guggenheim, UBS, Needham, Raymond James, Oppenheimer, Robert W. Baird in the past 90 days.